An NCI-designated Comprehensive Cancer Center

Markus Kalkum, Ph.D.

Professor, Department of Molecular Imaging & Therapy
Research Focus
  • Mass Spectrometry
  • Microbiology
  • Immunology and Cancer
Director, Mass Spectrometry & Proteomics Core
Other Languages Spoken
  • English
  • German
  • Spanish
Markus Kalkum, Ph.D., is director of the Mass Spectrometry & Proteomics Core at City of Hope. His research areas include mass spectrometry, microbiology and immunology. In particular, he employs mass spectrometry and proteomics to develop novel diagnostic assays and vaccines. This includes developing mass spectrometric methods for the quantitative analysis of proteins and other molecules in complex biological samples. He is generating novel biochemical assays for the ultrasensitive detection of functional biomolecules.
His goal is to improve the early diagnosis and prevention of emerging and of frequently underdiagnosed diseases, including opportunistic fungal and bacterial infections. He is advancing mycosis vaccine development and is studying immunomodulatory compounds of the gut microbiome. These activities are aimed at protecting cancer patients from opportunistic infections, improving cancer treatment outcomes.

To view a complete list of all publications on Pubmed, a public database, please click below.

View all Publications

In The News
An Expert's Voice
City of Hope News

City of Hope scientists identify first invasive case of rare mold in a cancer patient

Microbes in Space | City of Hope

Can terrestrial microbes survive in outer space? City of Hope and NASA team up to find out

Microbes in Space | City of Hope

City of Hope and NASA are studying microbes in space